Literature DB >> 10323211

Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus.

D D Eckels1, H Zhou, T H Bian, H Wang.   

Abstract

Numerous investigators have postulated that one mechanism by which hepatitis C virus (HCV) may evade the immune system is through the formation of escape mutants. This hypothesis is based largely on the observed mutability of the viral genome resulting in evolution of diverse quasispecies over the course of infection. That such diversification is a product of viral RNA polymerase infidelity, immune-driven selection or a combination of the two processes has not been addressed. We have examined sequence variability in a specific segment of HCV RNA encoding a known immunodominant region of the viral helicase, amino acids 358-375 of the non-structural 3 protein. Using sequence-specific oligonucleotide probe hybridization and automated DNA sequencing, we report a high frequency of mutations, essentially all of which result in amino acid replacements. To assess the biological impact of such mutations, corresponding chemically synthesized peptides were compared to wild-type peptide in T cell proliferation assays. We observed that a sizeable fraction of such peptides stimulated attenuated or negligible levels of proliferation by peripheral T cells from a chronically infected patient. This observation is consistent with expectations for immune-mediated selection of escape variants at the epitope level. We postulate that such a mechanism may be important in the immunopathogenesis of HCV infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323211     DOI: 10.1093/intimm/11.4.577

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  20 in total

Review 1.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms.

Authors:  Alessandro Perrella; Luigi Atripaldi; Pasquale Bellopede; Tommaso Patarino; Costanza Sbreglia; Giovanni Tarantino; Paolo Sorrentino; Paolo Conca; Luca Ruggiero; Oreste Perrella
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

3.  Antigenic cooperation among intrahost HCV variants organized into a complex network of cross-immunoreactivity.

Authors:  Pavel Skums; Leonid Bunimovich; Yury Khudyakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

4.  Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

Authors:  J T Gerlach; A Ulsenheimer; N H Grüner; M-C Jung; W Schraut; C-A Schirren; M Heeg; S Scholz; K Witter; R Zahn; A Vogler; R Zachoval; G R Pape; H M Diepolder
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Cytolytic CD4(+) T cells in viral immunity.

Authors:  Damien Z Soghoian; Hendrik Streeck
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

6.  Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C.

Authors:  Deepak Kumar; Abdul Malik; Mohammad Asim; Anita Chakravarti; Rakha-H Das; Premashis Kar
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 7.  CD4+ T cell responses in hepatitis C virus infection.

Authors:  Nasser Semmo; Paul Klenerman
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 8.  Sequence diversity of hepatitis C virus: implications for immune control and therapy.

Authors:  Joerg Timm; Michael Roggendorf
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

9.  CD4+ T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to Tregs.

Authors:  Matthew F Cusick; Jane E Libbey; Joan Cox Gill; Robert S Fujinami; David D Eckels
Journal:  Future Virol       Date:  2013-07       Impact factor: 1.831

10.  In vitro antigen-specific induction of IL-22 in human subjects that resolved HCV infection.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami; David D Eckels
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.